Published in J Clin Invest on May 01, 1993
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A (2000) 3.01
Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19
Role of tissue factor in cancer. J Clin Oncol (2009) 1.91
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation (2012) 1.70
EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am J Pathol (2005) 1.62
Shear stress induction of the tissue factor gene. J Clin Invest (1997) 1.35
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Increased responsiveness of human coronary artery endothelial cells in inflammation and coagulation. Mediators Inflamm (2010) 0.88
Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin. J Biol Chem (2009) 0.85
Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol (2009) 0.81
Role of the protein C receptor in cancer progression. Thromb Res (2014) 0.79
Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A (2001) 0.78
Simple hemorrhage induces tissue factor mRNA in the liver. Surg Today (1997) 0.78
Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion. PLoS One (2011) 0.77
Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci (Elite Ed) (2012) 0.77
Phenotypic transformation and migration of adventitial cells following angioplasty. Exp Ther Med (2012) 0.76
Peroxisome Proliferator-Activated Receptor α Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury. PPAR Res (2012) 0.75
Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology. J Interv Card Electrophysiol (2001) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
The biology of platelet-derived growth factor. Cell (1986) 7.17
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med (1979) 6.39
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest (1983) 6.05
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Tissue factor and hemostasis. Blood (1988) 3.15
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A (1977) 2.79
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation (1983) 2.59
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A (1986) 2.43
Role of basic fibroblast growth factor in vascular lesion formation. Circ Res (1991) 2.38
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest (1987) 1.74
Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol (1990) 1.66
The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest (1968) 1.57
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Insights into the pathogenesis of acute ischemic syndromes. Circulation (1988) 1.50
Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation (1982) 1.44
Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem (1989) 1.44
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol (1989) 1.34
Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels (1980) 1.32
The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem (1990) 1.28
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest (1982) 1.22
Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res (1989) 1.19
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation (1989) 1.19
Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol (1989) 1.13
Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis (1989) 1.12
Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol (1989) 1.09
JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res (1992) 1.06
Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation (1987) 1.00
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol (1984) 0.97
Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol (1991) 0.95
Ultrastructural changes in re-endothelialized and non-endothelialized rabbit aortic neo-intima following re-injury with a balloon catheter. Br J Exp Pathol (1984) 0.93
Fate of fibrinogen in human arterial intima. Arteriosclerosis (1990) 0.91
Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol (1986) 0.87
Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplasty. Am Heart J (1989) 0.84
Binding of the protein component of tissue factor to phospholipids. Biochemistry (1970) 0.82
Blood coagulation. Annu Rev Biochem (1980) 4.27
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature (1996) 3.40
Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci U S A (1972) 3.24
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A (1971) 3.13
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med (2001) 2.26
Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. J Biol Chem (1977) 2.21
Divergent orientation of transcription from the biotin locus of Escherichia coli. J Mol Biol (1971) 2.18
Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg (1998) 2.17
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13
Tissue factor (thromboplastin): localization to plasma membranes by peroxidase-conjugated antibodies. Science (1972) 2.07
Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05
Purification and characterization of bovine tissue factor. J Biol Chem (1981) 1.99
Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest (1996) 1.92
Tissue factor revisited. Prog Hemost Thromb (1982) 1.86
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Controls and polarity of transcription during bacteriophage T4 development. J Mol Biol (1971) 1.77
Fractionation of the complementary strands of coliphage T4 DNA based on the asymmetric distribution of the poly U and poly U,G binding sites. Virology (1968) 1.75
Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation (1999) 1.74
Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. Genes Dev (1987) 1.74
Ontogenesis of cell-mediated immunity in murine thymocytes and spleen cells and its acceleration by thymosin, a thymic hormone. J Immunol (1971) 1.73
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A (1987) 1.71
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost (2008) 1.70
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry (1986) 1.68
Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci U S A (1989) 1.67
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost (2003) 1.64
The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. A review of ten years' experience. Am J Cardiol (1970) 1.64
Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation (1997) 1.62
Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation (1992) 1.61
Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood (1992) 1.61
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood (2000) 1.59
Release of active tissue factor by human arterial smooth muscle cells. Circ Res (2000) 1.57
Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery (1999) 1.52
Association of tissue factor activity with the surface of cultured cells. J Clin Invest (1975) 1.52
Orientation and control of transcription in E. coli phage lambda. Nature (1969) 1.43
Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem (1980) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci U S A (2001) 1.33
Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol (2008) 1.33
Cloning and characterization of mammalian myosin regulatory light chain (RLC) cDNA: the RLC gene is expressed in smooth, sarcomeric, and nonmuscle tissues. J Cell Biol (1987) 1.32
An inhibitory monoclonal antibody against human tissue factor. Blood (1987) 1.30
The reaction between bovine brain tissue factor and factors VII and X. Biochemistry (1966) 1.30
Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol (1993) 1.29
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem (1997) 1.29
Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J Biol Chem (1994) 1.28
In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest (1996) 1.26
Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat (2008) 1.25
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology (2002) 1.25
Transcriptional controls in developing bacteriophages. J Cell Physiol (1969) 1.25
Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. J Biol Chem (1994) 1.24
Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII. J Biol Chem (1975) 1.24
Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med (1989) 1.23
Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry (1988) 1.22
Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells. J Biol Chem (1991) 1.22
Orientation of transcription for the galactose operon as determined by hybridization of gal mRNA with the separated DNA strands of coliphages lambda-dg. J Mol Biol (1968) 1.21
Activation of bovine factor VII by hageman factor fragments. Blood (1977) 1.20
Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry (1992) 1.20
The tissue factor pathway of blood coagulation. Prog Hemost Thromb (1972) 1.19
Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest (1985) 1.19
Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res (1987) 1.18
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Identification of active tissue factor in human coronary atheroma. Circulation (1996) 1.18
Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost (1997) 1.18
The Specific Heat of Human Blood. Science (1948) 1.17
An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage. Biochemistry (1986) 1.16
Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol (1991) 1.15
Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology (1997) 1.14
Spontaneous in vitro transformation of human fibroblasts. J Natl Cancer Inst (1984) 1.14
Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol (2000) 1.14
Attachment of osteocyte cell processes to the bone matrix. Anat Rec (Hoboken) (2009) 1.13
Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab (1993) 1.13
Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery (1998) 1.13
An assay for coagulation factor VII using factor VII-depleted bovine plasma. J Lab Clin Med (1974) 1.12
Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer (1999) 1.10
Decompression of the spinal cord improves recovery after acute experimental spinal cord compression injury. Paraplegia (1987) 1.10
Developmental expression of mouse Krüppel-like transcription factor KLF7 suggests a potential role in neurogenesis. Dev Biol (2001) 1.09
Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J Biol Chem (1976) 1.08
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation (1996) 1.08
Divergent orientation of transcription from the arginine gene ECBH cluster of Escherichia coli. J Bacteriol (1974) 1.07
Human vascular smooth muscle cells possess functional CCR5. J Biol Chem (2000) 1.06
Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J Neurosurg (2001) 1.06
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology (2003) 1.05